Henderson Group
http://www.henderson.comHenderson Group, the holding company for Henderson Global Investors, is a global asset management firm based in London, England. The firm invests in a broad range of asset classes including equities, fixed income, property, and private capital for its institutional, retail and high net-worth clients.
View Older Stories View More Recent Stories
-
Form SCHEDULE 13G/A WEX Inc. Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Mirum Pharmaceuticals, Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A TELEFLEX INC Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A CIMPRESS plc Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A SOLENO THERAPEUTICS INC Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Ascendis Pharma A/S Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A AVADEL PHARMACEUTICALS Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Perspective Therapeutics Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Applied Therapeutics, Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Caesars Entertainment, Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A IMMUNIC, INC. Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A PepGen Inc. Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A 4D Molecular Therapeutic Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A NEOGENOMICS INC Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A PRECISION BIOSCIENCES Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A CytomX Therapeutics, Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Neurogene Inc. Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G Entrada Therapeutics, Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G Edgewise Therapeutics, Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G Revolution Medicines, Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G Forte Biosciences, Inc. Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G Janux Therapeutics, Inc. Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G Avidity Biosciences, Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G Protara Therapeutics, Filed by: JANUS HENDERSON GROUP PLC
-
Victory Park Capital Expands Legal Credit Team, Welcomes Hugo Lestiboudois as Principal
-
Form SCHEDULE 13G/A JANUS HENDERSON GROUP Filed by: Capital Research Global Investors
-
Form SCHEDULE 13G/A 89bio, Inc. Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G BRIGHT MINDS BIOSCIENCES Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Beauty Health Co Filed by: JANUS HENDERSON GROUP PLC
-
Janus Henderson’s pioneering AAA CLO ETF (JAAA) surpasses $20 billion in AUM
-
Janus Henderson Launches Transformational Growth Equities ETF (JXX)
-
JPMorgan Upgrades Janus Henderson Group (JHG) to Overweight
-
Janus Henderson to Present at the UBS Financial Services and BofA Securities Financial Services Conferences
-
Janus Henderson Group plc (JHG) Tops Q4 EPS by 11c
-
Janus Henderson Group plc Reports Fourth Quarter and Full-Year 2024 Results
-
Form 8-K JANUS HENDERSON GROUP For: Jan 31
-
Form SCHEDULE 13G Surgery Partners, Inc. Filed by: JANUS HENDERSON GROUP PLC
-
Form S-4/A Janus Henderson US (Hold Filed by: JANUS HENDERSON GROUP PLC
-
TIFIN AMP Announces Strategic Partnership with Janus Henderson for AI-Driven Distribution Solutions
-
Form SCHEDULE 13G/A Larimar Therapeutics, Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Monopar Therapeutics Filed by: JANUS HENDERSON GROUP PLC
-
Form 3 JANUS HENDERSON GROUP For: Jan 01 Filed by: PODZOROV MEGAN
-
Goldman Sachs Upgrades Janus Henderson Group (JHG) to Neutral
-
Janus Henderson to Report Fourth Quarter and Full-Year 2024 Results
-
KBW Announces Index Rebalancing for Fourth-Quarter 2024
-
Form S-4/A Janus Henderson US (Hold Filed by: JANUS HENDERSON GROUP PLC
-
Form SC 13G/A Benitec Biopharma Inc. Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Mereo BioPharma Group Filed by: JANUS HENDERSON GROUP PLC
-
Form SCHEDULE 13G/A Applied Therapeutics, Filed by: JANUS HENDERSON GROUP PLC

